Universal Health Services (UHS) Hits 52-Week Low On Dull Q3
Zacks Investment Research | Nov 08, 2017 10:05PM ET
Shares of Universal Health Services Inc. (NYSE:UHS) tumbled to a 52-week low of $99.56 during the trading session on Nov 8. The slide is believed to have stemmed from poor third-quarter results and a subsequent guidance cut.
Over the past 52 weeks, shares of Universal Health Services have ranged from a low of $99.56 to a high of $129.74. The average volume of shares traded over the last three months is approximately 0.8 million.
Poor Results Bother
Investors were particularly disappointed by lackluster third-quarter earnings which missed the Zacks Consensus Estimate by 3.5%. The top line also missed the estimate by 2%. This was the second miss in a row.
Quite concerning was weak volumes reported by both operating segments — Acute Care and Behavioral Health Hospitals.
In the Acute Care segment, adjusted admission growth slowed to 3.5% in the third quarter compared with growth of 6.5% in the year-ago quarter. Likewise, adjusted patent day witnessed growth of 1.5% versus 3.4% in the third quarter of 2016. Revenue per adjusted admission declined 0.6% compared with growth of 4.4% in last year quarter.
Softness also persisted in the Behavioral Health Hospitals segment with adjusted admission growth declining to 1.1% in the third quarter compared with growth of 1.6% reported in the year-ago quarter. In the same vein, adjusted patent day declined 0.2% versus growth of 1.6% in third-quarter 2016. Revenue per adjusted admission grew just 1.3% compared with growth of 3.3% in the year-ago quarter.
Weakness in volumes from this segment is expected to persist in the coming quarter.
Uninspiring Outlook
Shares also took a toll from its tepid 2017 earnings guidance. Based on the operating trends and financial results experienced during the first nine months of 2017, the company revised its estimated range of adjusted net income attributable for 2017 to $7.25 to $7.50 per diluted share from the previously provided range of $7.50 to $8 per diluted share.
This revised guidance, which excludes the effect of electronic health records impact for the year, as well as the impact of the adoption of ASU 2016-09, decreases the lower end of the previously provided range by approximately 3.3%, and decreases the upper end of the previously provided range by approximately 6.3%.
Price Performance
In a year’s time, the stock has lost 16.7%, significantly underperforming the Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.